Fig. 2From: Helicobacter pylori reversing the landscape of neoadjuvant immunotherapy for microsatellite stable gastric cancer: a multicenter cohort studyChanges in five Helicobacter pylori-positive GC patients before and after neoadjuvant therapy from TRG 1–5, respectivelyBack to article page